Indeed, germline BRCA2 and PALB2 mutations and subsequent loss of function have been associated with several cancers, including medulloblastomas, where structural aberrations of chr17, which harbors TP53 in its p arms, have been reported.31 This evidence concerns the gene TP53 and cancer.